Article

Placental oxidative stress: From miscarriage to preeclampsia

Department of Anatomy, University of Cambridge, Cambridge, United Kingdom.
Journal of the Society for Gynecologic Investigation (Impact Factor: 2.26). 10/2004; 11(6):342-52. DOI: 10.1016/j.jsgi.2004.03.003
Source: PubMed

ABSTRACT To review the role of oxidative stress in two common placental-related disorders of pregnancy, miscarriage and preeclampsia.
Review of published literature.
Miscarriage and preeclampsia manifest at contrasting stages of pregnancy, yet both have their roots in deficient trophoblast invasion during early gestation. Early after implantation, endovascular trophoblast cells migrate down the lumens of spiral arteries, and are associated with their physiological conversion into flaccid conduits. Initially these cells occlude the arteries, limiting maternal blood flow into the placenta. The embryo therefore develops in a low oxygen environment, protecting differentiating cells from damaging free radicals. Once embryogenesis is complete, the maternal intervillous circulation becomes fully established, and intraplacental oxygen concentration rises threefold. Onset of the circulation is normally a progressive periphery-center phenomenon, and high levels of oxidative stress in the periphery may induce formation of the chorion laeve. If trophoblast invasion is severely impaired, plugging of the spiral arteries is incomplete, and onset of the maternal intervillous circulation is premature and widespread throughout the placenta. Syncytiotrophoblastic oxidative damage is extensive, and likely a major contributory factor to miscarriage. Between these two extremes will be found differing degrees of trophoblast invasion compatible with ongoing pregnancy but resulting in deficient conversion of the spiral arteries and an ischemia-reperfusion-type phenomenon. Placental perfusion will be impaired to a greater or lesser extent, generating commensurate placental oxidative stress that is a major contributory factor to preeclampsia.
Miscarriage, missed miscarriage, and early- and late-onset preeclampsia represent a spectrum of disorders secondary to deficient trophoblast invasion.

0 Bookmarks
 · 
104 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background The endocannabinoid system plays a key role in female reproduction, including implantation, decidualization and placentation. In the present study, we aimed to analyze cannabinoid receptor 1 (CB1), CB2 and fatty acid amid hydrolase (FAAH) expressions and localization in normal and preeclamptic placenta, in order to determine whether placental endocannabinoid expression pattern differs between normal pregnancy and preeclampsia.Methods Eighteen preeclamptic patients and 18 normotensive, healthy pregnant women with uncomplicated pregnancies were involved in our case¿control study. We determined CB1, CB2 and FAAH expressions by Western blotting and immunohistochemistry in placental samples collected directly after Cesarean section.ResultsCB1 expression semi-quantified by Western blotting was significantly higher in preeclamptic placenta, and these findings were confirmed by immunohistochemistry. CB1 immunoreactivity was markedly stronger in syncytiotrophoblasts, the mesenchymal core, decidua, villous capillary endothelial and smooth muscle cells, as well as in the amnion in preeclamptic samples compared to normal pregnancies. However, we did not find significant differences between preeclamptic and normal placenta in terms of CB2 and FAAH expressions and immunoreactivity.Conclusions We observed markedly higher expression of CB1 protein in preeclamptic placental tissue. Increased CB1 expression might cause abnormal decidualization and impair trophoblast invasion, thus being involved in the pathogenesis of preeclampsia. Nevertheless, we did not find significant differences between preeclamptic and normal placental tissue regarding CB2 and FAAH expressions. While the detailed pathogenesis of preeclampsia is still unclear, the endocannabinoid system could play a role in the development of the disease.
    BMC Pregnancy and Childbirth 12/2014; 14(1):395. DOI:10.1186/s12884-014-0395-x · 2.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. The concentration of reduced (GSH), oxidized (GSSG) and total (GSH + GSSG) glutathione, the level of malondialdehyde (MDA), and the general antioxidant activity (GAA) was determined in blood plasma and cervicovaginal washing fluid of pregnant women infected and non-infected with human papilloma virus (HPV). Materials and methods. The population of 213 pregnant women visiting one of the Centers of the Central Outpatient Clinic of Vilnius (Lithuania) in 2008–2010 was includ-ed in the study. These women were examined for HPV infection and its type. The tests were performed in the first and third trimesters of pregnancy in blood plasma and cer-vicovaginal washing fluid. The MDA level was tested by the thiobarbituric acid assay. The amount of glutathione forms was determined using a recycling system with 5,5'-dithiobis 2-nitrobenzoic acid and glutathione reductase. General antioxidant activity (GAA) was measured by Tween 80 oxidation in a specific test. All parameters were analyzed spectro-photometrically. Results. The concentration of all glutathione forms and GAA reduced during preg-nancy, while the MDA level was enhanced in the blood plasma of all women included in the analysis. Only two of these parameters changed in the cervicovaginal washing fluid. No significant change of GAA was determined comparing groups of women while con-sidering HPV infection. The GSH / GSSG ratio significantly increased in HPV-negative and decreased in HPV-positive women. While comparing HPV-positive and HPV-negative women of similar age, no significant difference of any parameter was found in cervicovagi-nal washing fluid and in blood plasma in the third trimester. In the first trimester the GSSG level was significantly lower, the GSH level was higher, and the GSH / GSSG ratio was twice higher in HPV-infected women. All pregnant women were compared with non-pregnant women to confirm the influence of pregnancy on the MDA level. In the first trimester, this parameter for pregnant women was close to that of non-pregnant women, while with the developing pregnancy the MDA level increased 1.6 times. No significant difference in the parameter was determined for pregnant women with HPV infection. Conclusions. A decrease of GSH concentration and an increase of MDA level in blood plasma with the development of pregnancy confirmed the presence of a general oxida-tive stress. The lower levels of GSH and GSH + GSSG in the cervicovaginal washing fluid, if to compare the two trimesters of pregnancy, can be considered as markers of a local oxidative stress. HPV infection depressed the antioxidative system in general and did not affect it at the local level. Systemic oxidative stress, rather than HPV infection, influenced the lipid peroxidation process during pregnancy. The level of MDA is recommended to be tested also during a normal pregnancy, although this parameter should not be considered as an additional biomarker of cervical carcinoma risk. Changes of the antioxidative system variables could induce a deep oxidative imbalance during a pathological pregnancy, and oxidative stress might cause a persistent HPV infection, suggesting the importance of the additional screening of HPV-infected women after delivery.
    01/2010; 17(3). DOI:10.2478/v10140-010-0011-y
  • [Show abstract] [Hide abstract]
    ABSTRACT: Do any proteomic biomarkers previously identified for pre-eclampsia (PE) overlap with those identified in women with polycystic ovary syndrome (PCOS).
    Human Reproduction 10/2014; DOI:10.1093/humrep/deu268 · 4.59 Impact Factor

Full-text

Download
58 Downloads
Available from
Dec 15, 2014